SHORT ARTICLE

Correction of β-thalassemia mutant by base editor in human embryos

  • Puping Liang 1,2 ,
  • Chenhui Ding 2 ,
  • Hongwei Sun 1 ,
  • Xiaowei Xie 1 ,
  • Yanwen Xu 2 ,
  • Xiya Zhang 1 ,
  • Ying Sun 1 ,
  • Yuanyan Xiong 1 ,
  • Wenbin Ma 1 ,
  • Yongxiang Liu 2 ,
  • Yali Wang 2 ,
  • Jianpei Fang 3 ,
  • Dan Liu 4 ,
  • Zhou Songyang , 1,2,4 ,
  • Canquan Zhou , 2 ,
  • Junjiu Huang , 1,2
Expand
  • 1. Key Laboratory of Gene Engineering of the Ministry of Education, Guangzhou Key Laboratory of Healthy Aging Research and State Key Laboratory of Biocontrol, SYSU-BCM Joint Research Center, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China
  • 2. Key Laboratory of Reproductive Medicine of Guangdong Province, School of Life Sciences and the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510275, China
  • 3. Department of Pediatrics, Second Affiliated Hospital, Sun Yat-sen University, Guangzhou 510120, China
  • 4. Verna and Marrs Mclean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA

Received date: 07 Sep 2017

Accepted date: 15 Sep 2017

Published date: 30 Nov 2017

Copyright

2017 The Author(s) 2017. This article is an open access publication

Abstract

β-Thalassemia is a global health issue, caused by mutations in the HBB gene. Among these mutations, HBB −28 (A>G) mutations is one of the three most common mutations in China and Southeast Asia patients with β-thalassemia. Correcting this mutation in human embryos may prevent the disease being passed onto future generations and cure anemia. Here we report the first study using base editor (BE) system to correct disease mutant in human embryos. Firstly, we produced a 293T cell line with an exogenousHBB −28 (A>G) mutant fragment for gRNAs and targeting efficiency evaluation. Then we collected primary skin fibroblast cells from a β-thalassemia patient withHBB −28 (A>G) homozygous mutation. Data showed that base editor could precisely correct HBB −28 (A>G) mutation in the patient’s primary cells. To model homozygous mutation disease embryos, we constructed nuclear transfer embryos by fusing the lymphocyte or skin fibroblast cells with enucleatedin vitro matured (IVM) oocytes. Notably, the gene correction efficiency was over 23.0% in these embryos by base editor. Although these embryos were still mosaic, the percentage of repaired blastomeres was over 20.0%. In addition, we found that base editor variants, with narrowed deamination window, could promote G-to-A conversion atHBB −28 site precisely in human embryos. Collectively, this study demonstrated the feasibility of curing genetic disease in human somatic cells and embryos by base editor system.

Cite this article

Puping Liang , Chenhui Ding , Hongwei Sun , Xiaowei Xie , Yanwen Xu , Xiya Zhang , Ying Sun , Yuanyan Xiong , Wenbin Ma , Yongxiang Liu , Yali Wang , Jianpei Fang , Dan Liu , Zhou Songyang , Canquan Zhou , Junjiu Huang . Correction of β-thalassemia mutant by base editor in human embryos[J]. Protein & Cell, 2017 , 8(11) : 811 -822 . DOI: 10.1007/s13238-017-0475-6

1
CaoA, Galanello R (2010) Beta-thalassemia.Genet Med12:61–76

DOI

2
ChernJP, SuS, LinKH, Chang SH, LuMY , JouST, LinDT, HoWL, Lin KS (2007) Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan.Pediatr Blood Cancer48:550–554

DOI

3
ChenY, WangZ, NiH, XuY, ChenQ, Jiang L (2017) CRISPR/Cas9-mediated base-editing system efficiently generates gain-of-function mutations in Arabidopsis.Sci China Life Sci.

DOI

4
DeverDP, BakRO, ReinischA, Camarena J, WashingtonG , NicolasCE, Pavel-Dinu M, SaxenaN , WilkensAB, MantriS (2016) CRISPR/Cas9 beta-globin gene targeting in human haematopoietic stem cells.Nature539:384–389

DOI

5
DingC, HuangS, QiQ, FuR, ZhuW, Cai B, HongP , LiuZ, GuT, ZengY (2015) Derivation of a homozygous human androgenetic embryonic stem cell line.Stem Cells Dev24:2307–2316

DOI

6
GalanelloR, OrigaR (2010) Beta-thalassemia. Orphanet J Rare Dis5:11

DOI

7
HashimotoM,Yamashita Y, TakemotoT (2016) Electroporation of Cas9 protein/sgRNA into early pronuclear zygotes generates non-mosaic mutants in the mouse.Dev Biol418:1–9

DOI

8
HohmannS (2017) Editor’s comment on “CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein”.Mol Genet Genom292:535–536

DOI

9
KangX, HeW, HuangY, Yu Q, ChenY , GaoX, SunX, FanY (2016) Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.J Assist Reprod Genet33:581–588

DOI

10
KimD, LimK, KimST, Yoon SH,KimK , RyuSM, KimJS (2017a) Genome-wide target specificities of CRISPR RNA-guided programmable deaminases.Nat Biotechnol35:475–480

DOI

11
KimK, RyuSM, KimST, Baek G, KimD , LimK, ChungE, KimS,Kim JS (2017b) Highly efficient RNA-guided base editing in mouse embryos.Nat Biotechnol35(5):435–437

DOI

12
KimK, RyuSM, KimST, Baek G, KimD , LimK, ChungE, KimS, Kim JS (2017c) Highly efficient RNA-guided base editing in mouse embryos.Nat Biotechnol35:435–437

DOI

13
KimYB, KomorAC, LevyJM, Packer MS, ZhaoKT , LiuDR (2017d) Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions.Nat Biotechnol35:371–376

DOI

14
KomorAC, KimYB, PackerMS, Zuris JA, LiuDR (2016)Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.Nature533:420–424

DOI

15
LiJ, SunY, DuJ, ZhaoY, XiaL (2016) Generation of targeted point mutations in rice by a modified CRISPR/Cas9 system.Mol Plant10(3):526–529

DOI

16
LiG, LiuY, ZengY, Li J, WangL , YangG, ChenD, ShangX, Chen J, HuangX et al (2017a) Highly efficient and precise base editing in discarded human tripronuclear embryos.Protein Cell.

DOI

17
LiJ, SunY, DuJ, ZhaoY, XiaL (2017b) Generation of targeted point mutations in rice by a modified CRISPR/Cas9 system.Mol Plant10:526–529

DOI

18
LiangP, XuY, ZhangX, Ding C, HuangR , ZhangZ, LvJ, XieX,Chen Y, LiY (2015) CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.Protein Cell6:363–372

DOI

19
LiangP, SunH, SunY, Zhang X, XieX, ZhangJ,ZhangZ, ChenY,Ding C,XiongY (2017) Effective gene editing by high-fidelity base editor 2 in mouse zygotes.Protein Cell8(8):601–611

DOI

20
LuY, ZhuJK (2016) Precise editing of a target base in the rice genome using a modified CRISPR/Cas9 system.Mol Plant10 (3):523–525

DOI

21
MaH,Marti-Gutierrez N, ParkS , WuJ, LeeY, SuzukiK, Koski A, JiD , HayamaT, AhmedR (2017) Correction of a pathogenic gene mutation in human embryos.Nature548(7668):413–419

DOI

22
OrkinSH, SextonJP, ChengTC, Goff SC, GiardinaPJ , LeeJI,KazazianHH Jr (1983) ATA box transcription mutation in betathalassemia.Nucleic Acids Res11:4727–4734

DOI

23
RenB, YanF, KuangY, Li N, ZhangD , LinH, ZhouH (2017) A CRISPR/Cas9 toolkit for efficient targeted base editing to induce genetic variations in rice.Sci China Life Sci60(5):516–519

DOI

24
TangL, ZengY, DuH, GongM, PengJ, Zhang B,LeiM , ZhaoF, WangW, LiX (2017) CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein.Mol Genet Genom292:525–533

DOI

25
WangL,XueW, YanL, Li X,WeiJ , ChenM, WuJ, YangB, Yang L, ChenJ (2017) Enhanced base editing by co-expression of free uracil DNA glycosylase inhibitor.Cell Res.

DOI

26
WeatherallDJ (2010) The inherited diseases of hemoglobin are an emerging global health burden.Blood115:4331–4336

DOI

27
WuHP, LinCL, ChangYC, Wu KH, LeiRL , PengCT, WengT, TaiYM, Chao YH (2017) Survival and complication rates in patients with thalassemia major in Taiwan.Pediatr Blood Cancer64:135–138

DOI

28
ZhangX, LiangP, DingC, Zhang Z, ZhouJ , XieX, HuangR, SunY, Sun H, ZhangJ (2016) Efficient Production of Gene-Modified Mice using Staphylococcus aureus Cas9.Sci Rep6:32565

DOI

29
ZongY, WangY, LiC, ZhangR, ChenK, Ran Y, QiuJL , WangD, GaoC (2017) Precise base editing in rice, wheat and maize with a Cas9- cytidine deaminase fusion.Nat Biotechnol35(5):438–440

DOI

30
ZhouC, ZhangM, WeiY, Sun Y,SunY , PanH, YaoN, ZhongW, Li Y, LiW , YangH (2017) Highly efficient base editing in human tripronuclear zygotes.Protein Cell.

DOI

Outlines

/